z-logo
Premium
Cadherins, catenins and APC in pleural malignant mesothelioma
Author(s) -
Abutaily AS,
Collins JE,
Roche WR
Publication year - 2003
Publication title -
the journal of pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.964
H-Index - 184
eISSN - 1096-9896
pISSN - 0022-3417
DOI - 10.1002/path.1458
Subject(s) - mesothelioma , catenin , pathology , osteopontin , cadherin , beta catenin , immunohistochemistry , gsk3b , cancer research , biology , gsk 3 , wnt signaling pathway , medicine , phosphorylation , cell , gene , immunology , microbiology and biotechnology , genetics
Malignant mesothelioma is an aggressive disease of the pleura, and less commonly the peritoneum, with a very poor prognosis. The present study has examined the expression of cell adhesion molecules including cadherins, catenins, and APC in order to determine whether abnormal expression of components of the Wnt signalling pathway contribute to the variable phenotype of malignant mesothelioma. Sixty‐three malignant mesotheliomas and nine cases of reactive mesothelial hyperplasia were analysed by immunohistochemistry for E‐cadherin, N‐cadherin, α‐catenin, β‐catenin, and the C‐ and N‐terminals of APC. In addition, DNA was extracted from formalin‐fixed, paraffin wax blocks, and a 226 bp fragment of exon 3 of the β‐catenin gene was amplified, sequenced, and screened for activating mutations in the glycogen synthase kinase 3β (GSK‐3β) phosphorylation targets. E‐cadherin expression was detected in 48% of the epithelioid mesotheliomas but was observed in only 7% of sarcomatoid mesotheliomas. N‐cadherin, α‐catenin, β‐catenin, and the C‐ and N‐terminals of APC did not show differential expression between the mesothelioma phenotypes. Abnormal nuclear localization of β‐catenin was demonstrated in 19% of mesotheliomas. Mutations of β‐catenin phosphorylation sites were not detected in any of the 62 mesotheliomas examined. Positive staining for the N‐terminal of APC was seen in all of the cases of reactive mesothelial hyperplasia, as well as in all the mesotheliomas. Staining for the C‐terminal of APC was negative in 23% mesotheliomas, despite being present in all the cases of reactive hyperplasia. The present study provides the first evidence that β‐catenin accumulates in the nucleus in malignant mesotheliomas. In addition, APC expression was altered in some mesotheliomas, suggesting that a truncated APC gene product may contribute to abnormal Wnt signalling and dysregulation of cell proliferation in malignant mesothelioma. Copyright © 2003 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here